Nuijts Rudy M M A, Abhilakh Missier Kiran A, Nabar Vaisjali A, Japing Wouter J
Department of Ophthalmology, Academic Hospital Maastricht, Maastricht, The Netherlands.
Ophthalmology. 2004 Jun;111(6):1086-94. doi: 10.1016/j.ophtha.2003.09.045.
To determine the efficacy of Artisan toric iris-fixated lens implantation after penetrating keratoplasty to correct high ametropia and astigmatism.
Prospective, noncomparative case series.
Artisan toric lens implantation was performed in 16 eyes of 16 patients who were contact lens intolerant or were unable to wear glasses because of anisometropia, high astigmatism, or both.
Sixteen eyes of 16 patients received Artisan toric lenses for postkeratoplasty astigmatism, anisometropia, or both.
Manifest refraction, uncorrected and spectacle-corrected visual acuity, and corneal topography were performed before surgery and 1, 3, 6, 12, and 18 months after surgery. Efficacy, percent reduction of refractive astigmatism, topographical astigmatism, anisometropia of defocus, and the astigmatism correction index were determined. A patient satisfaction questionnaire and specular microscopy results were assessed.
The mean +/- standard deviation of the preoperative refractive cylinder was -6.66+/-1.93 diopters (D; range, -4.0 to -10.0 D), which was reduced to -2.08+/-1.33 D, -2.14+/-1.76 D, -1.98+/-1.65 D, -1.84+/-0.77 D, and -1.42+/-0.78 D at 1 month, 3 months, 6 months, 12 months, and the final follow-up examination (8.4+/-4.9 months), respectively. Spherical equivalent was reduced from -4.90+/-5.50 D before surgery to -0.96+/-0.86 D at the final follow-up. The uncorrected and best-corrected visual acuities were >/=20/40 in 42% and 100% of eyes, respectively. There was no loss of best-corrected visual acuity and a gain of at least 2 lines in 50% of eyes. The percent reduction in refractive astigmatism, topographical astigmatism, and anisometropia of defocus were 78.0+/-11.5%, 20.3+/-34.9%, and 77.0+/-12.0%, respectively. The astigmatism correction index was 102.8+/-18.6%. Satisfaction increased from 3.2 to 8.3 after implantation. The endothelial cell loss was 7.6+/-18.9% at 3 months and 16.6+/-20.4% at the last follow-up. In 1 patient, a reversible graft rejection occurred.
Artisan toric lens implantation after penetrating keratoplasty was effective for reduction of refractive astigmatism and ametropia. All patients were suitable for spectacle correction after implantation. A longer follow-up and a larger number of patients are needed to assess the safety and the effect of the lens on the corneal graft endothelium.
确定穿透性角膜移植术后植入Artisan有晶状体眼人工晶状体矫正高度屈光不正和散光的疗效。
前瞻性、非对照病例系列。
对16例因角膜接触镜不耐受或因屈光参差、高度散光或两者兼有而无法佩戴眼镜的患者的16只眼进行了Artisan有晶状体眼人工晶状体植入术。
16例患者的16只眼接受了Artisan有晶状体眼人工晶状体植入,用于矫正角膜移植术后的散光、屈光参差或两者。
在手术前以及手术后1个月、3个月、6个月、12个月和18个月进行显验光、未矫正和矫正视力以及角膜地形图检查。测定疗效、屈光性散光、地形性散光、散焦性屈光参差的减少百分比以及散光矫正指数。评估患者满意度问卷和角膜内皮显微镜检查结果。
术前屈光柱镜的平均值±标准差为-6.66±1.93屈光度(D;范围,-4.0至-10.0 D),在1个月、3个月、6个月、12个月和最终随访检查(8.4±4.9个月)时分别降至-2.08±1.33 D、-2.14±1.76 D、-1.98±1.65 D、-1.84±0.77 D和-1.42±0.78 D。等效球镜度从术前的-4.90±5.50 D降至最终随访时的-0.96±0.86 D。分别有42%和100%的眼未矫正视力和最佳矫正视力≥20/40。50%的眼最佳矫正视力无下降且至少提高了2行。屈光性散光、地形性散光和散焦性屈光参差的减少百分比分别为78.0±11.5%、20.3±34.9%和77.0±12.0%。散光矫正指数为102.8±18.6%。植入后满意度从3.2提高到8.3。3个月时内皮细胞损失为7.6±18.9%,最后一次随访时为16.6±20.4%。1例患者发生了可逆性移植排斥反应。
穿透性角膜移植术后植入Artisan有晶状体眼人工晶状体可有效降低屈光性散光和屈光不正。所有患者植入后均适合佩戴眼镜矫正。需要更长时间的随访和更多患者来评估该人工晶状体对角膜移植内皮的安全性和效果。